Obostrenie khronicheskoy obstruktivnoy bolezni legkikh. Prakticheskie rekomendatsii


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The problem of management of patients with exacerbation of chronic obstructive pulmonary disease (COPD) is discussed. Information on the etiology of COPD exacerbations, assessment of the severity of an exacerbation, pharmacotherapy of COPD exacerbations, prevention of thromboembolic complications, and the algorithm for management of patients with COPD exacerbation are presented.

Full Text

Restricted Access

References

  1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/
  2. Чучалин А.Г., Айсанов З.Р., Авдеев С.Н. и др. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких. М., 2014. Доступно на: http://www.pulmonology.ru/publications/guide.php?clear_cache=Y Хроническая обструктивная болезнь легких / Под ред. акад. РАМН А.Г. Чучалина. М., 2008. 567 с.
  3. Roche N., Huchon G. Epidemiology of chronic obstructive pulmonary disease. Rev. Prat. 2004; 54(13): 1408-13.
  4. World Health Report, 2000. Health systems: improving performance. Annex table 3. 2000 World Health Organization. Geneva, Switzerland.
  5. Lopez A., Murray C. The global burden of disease 1990-2020. Nat Med. 1998; 4: 1241-43.
  6. Fein A., Fein A. Management of acute exacerbations in chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 2000; 6(2): 122-26.
  7. Donaldson G., Seemungal T., Bhowmik A., et al. The relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57: 847-52.
  8. Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease. Proceed. Am. Thorac. Society. 2004; 1: 109-14.
  9. Sethi S., Murphy T. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 2355.
  10. Diederen B., van der Valk P., Kluytmans J., et al. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 2007; 30: 240-44.
  11. Kherad O., Rutschmann O. Viral Infections as a Cause of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation. Praxis. 2010; 99(4): 235-40.
  12. Lode H., Allewelt M., Balk S., et al. A prediction model for bacterial etiology in acute exacerbations of COPD. Infection. 2007; 35: 143-49.
  13. Anthonisen N., Manfreda J., Warren C., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern. Med. 1987; 106: 196-204.
  14. De Jong Y., Uil S., Grotjohan H., et al. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest. 2007; 132(6): 1741-47.
  15. Quon B., Gan W., Sin D. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2008; 133(3): 756-66.
  16. Aaron S., Vandemheen K., Hebert P., et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N. Engl. J. Med. 2003; 348: 2618-25.
  17. Синопальников А.И., Козлов Р.С., Романовских А.Г., Рачина С.А. Инфекционное обострение ХОБЛ: практические рекомендации по диагностике, лечению и профилактике. Российские Медицинские Вести. 2006; XI(1): 4-18.
  18. Синопальников А.И., Зайцев А.А. «Респираторные» фторхинолоны в лечении инфекционного обострения ХОБЛ. Справочник поликлинического врача. 2010; 4: 52-5.
  19. Cazzola M., Vinciguerra A., Beghi G., et al. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis. J. Chemother. 1995; 7(5): 432-41.
  20. Цой А.Н., Сафонова Е.В., Гучев И.А. Цефиксим. Клиническая эффективность при обострении нетяжелой хронической обструктивной болезни легких и влияние на развитие рецидивов заболевания. Лечащий врач. 2011; 1. Доступно на: http://www.lvrach.ru/2011/01/15435111/
  21. Зайцев А.А., Макаревич А.М. Короткие курсы левофлоксацина в терапии внебольничной пневмонии. Дыхание & Пульмонология и отоларингология. 2013; 1: 1-4.
  22. Lorenz J., Steinfeld P., Drath L., Keienburg T., et al. Efficacy and Tolerability of 5- vs 10-Day Cefixime Therapy in Acute Exacerbations of Chronic Bronchitis. Clin. Drug. Investig. 1998; 15(1): 13-20.
  23. Falagas M., Avgeri S., Matthaiou D., Dimopoulos G. Short-versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J. Antimicrob. Chemother. 2008; 62(3): 442-50.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies